Time Matters: Evaluating the Clinical and Infectious Outcomes in Rupture of Membranes
Gynecologic and Obstetric Investigation · 2025
DOI: 10.1159/000548662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2025. Verfasst von Raneen Abu Shqara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Raya Strauss Wing of Obstetrics and Gynecology Galilee Medical Center, Nahariya, Israel, raneena2@gmc.gov.il. Hauptthemen laut MEDLINE: Premature Rupture of Fetal Membranes, Chorioamnionitis, Fever. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives: The objectives of this study were to identify factors associated with intrapartum fever (IPF) and clinical chorioamnionitis in patients with term prelabor rupture of membranes (PROM) lasting
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Raya Strauss Wing of Obstetrics and Gynecology Galilee Medical Center, Nahariya, Israel, raneena2@gmc.gov.il.
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel, raneena2@gmc.gov.il.
- Raya Strauss Wing of Obstetrics and Gynecology Galilee Medical Center, Nahariya, Israel.
- Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Zitieren
APA
Abu Shqara, R., Lowenstein, L., & Frank Wolf, M. (2025). Time Matters: Evaluating the Clinical and Infectious Outcomes in Rupture of Membranes. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000548662
Vancouver
Abu Shqara R, Lowenstein L, Frank Wolf M. Time Matters: Evaluating the Clinical and Infectious Outcomes in Rupture of Membranes. Gynecologic and Obstetric Investigation. 2025. doi:10.1159/000548662
BibTeX
@article{AbuShqara2025,
author = {Abu Shqara, Raneen and Lowenstein, Lior and Frank Wolf, Maya},
title = {Time Matters: Evaluating the Clinical and Infectious Outcomes in Rupture of Membranes},
journal = {Gynecologic and Obstetric Investigation},
year = {2025},
doi = {10.1159/000548662}
}
EUVIMED